✨ Medicines Approval Notices




NEW ZEALAND GAZETTE

No. 80

Dated this 20th day of May 1991.

MAURICE WILLIAMSON, Associate Minister of Health.

go5337

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Tolrestat 200 mg Capsule Ayerst Laboratories, Division of Ayerst, McKenna and Harrison Inc., St Laurent, Quebec, Canada Alredase
Etodolac 200 mg Capsule Ayerst Laboratories Ltd., Andover, Hampshire, England or Ayerst Laboratories Pty Ltd., Paramatta, NSW, Australia Lodine
Cefotetan 0.5 g, 1 g, 2 g Powder for reconstitution for injection Les Laboratoires Principharm, Montreuil, France Apatef
Morphine hydrochloride 1 mg/ml, 2 mg/ml, 5 mg/ml, 10 mg/ml Solution for injection Delta West Ltd., Bentley, Western Australia Morphine Mixture
R metHuG-CSF 300 mcg/1 ml, 480 mcg/1.6 ml Solution for injection F Hoffman-La Roche Ltd., Basle, Switzerland Neupogen
Diclofenac diethylamine 1.16% Topical gel Ciba Geigy Ltd., Basle, Switzerland Voltaren Emulgel
Nafarelin acetate 2 mg/ml Metered dose nasal spray Usine Le Petit Paris, Leuville-sur-Orge, Montlhery, France Synarel
Calcipotriol 50 mcg/gm Ointment Leo Laboratories Ltd., Dublin, Ireland Daivonex
Famotidine 20 mg, 40 mg Tablet Pacific Pharmaceuticals Ltd., Mount Wellington, Auckland Famox
Pindolol 5 mg, 10 mg, 15 mg Tablet Novopharm Ltd., Scarborough, Ontario, Canada Vypen
Nonoxynol-9 1 gm Vaginal sponge Whitehall Laboratories, Division of American Home Product Corporation, Hammonton, New Jersey, United States of America Today Sponge

Dated this 20th day of May 1991.

MAURICE WILLIAMSON, Associate Minister of Health.

go5338

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Purified capsular polysaccharide 25 mcg Solution for injection Connaught Laboratories Inc., Swiftwater, Pennsylvania, United States of America ProHibit
Diphtheria toxoid protein 18 mcg
Thiomersal 50 mcg

This replaces the consent gazetted 11 April 1991.

Dated this 20th day of May 1991.

MAURICE WILLIAMSON, Associate Minister of Health.

go5548



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1991, No 80


NZLII PDF NZ Gazette 1991, No 80





✨ LLM interpretation of page content

πŸ₯ Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
20 May 1991
Medicines Act, New Medicines, Pharmaceutical Approvals, Drug Distribution
  • MAURICE WILLIAMSON, Associate Minister of Health

πŸ₯ Consent to Distribution of New Medicine (Replacement)

πŸ₯ Health & Social Welfare
20 May 1991
Medicines Act, New Medicine, Pharmaceutical Approval, Drug Distribution, Replacement Consent
  • MAURICE WILLIAMSON, Associate Minister of Health